LMNX

Q: What is the price of Luminex (LMNX) today?

The current price of Luminex (LMNX) is $ 13.16, representing a 0% gain over the past year. The stock began the year trading around $ 29.72 and is currently priced at $ 13.16. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Luminex (LMNX) pay dividends?

Luminex (LMNX) did not pay dividends over the past year.

Q: Is Luminex (LMNX) a good investment?

Luminex (LMNX) is currently trading at $ 13.16 with a P/E ratio of 25.65. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Luminex Corporation

Price

$ 13.16

return (12m)

0.00%

p/e

25.65

p/bv

1.24

DIVIDEND YIELD

0.00%

LMNX price

Luminex

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LMNX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

9.10%

3 months

-10.64%

1 year

0.00%

2 years

0.00%

5 years

-64.32%

10 years

-31.83%

Fundamentals LMNX

review the fundamentals of Luminex shares

P/E

25.65

Sector: -3.94 Industry: -3.94

P/S (PSR)

1.38

Sector: -4.28 Industry: -4.28

P/BV

1.24

Sector: 1.87 Industry: 1.87

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

2.88%

Sector: -67.34% Industry: -67.34%

ROE

4.84%

Sector: -68.37% Industry: -68.37%

ROIC

8.87%

Sector: -2,920.39% Industry: -2,920.39%

NET MARGIN

5.39%

Sector: -41.59% Industry: -41.59%

GROSS MARGIN

60.31%

Sector: 36.47% Industry: 36.47%

OPERATING MARGIN

12.40%

Sector: -40.38% Industry: -40.38%

EV/EBITDA

7.21

Sector: -4.08 Industry: -4.08

EV/EBIT

11.42

Sector: -4.15 Industry: -4.15

PRICE-TO-ASSETS

0.74

Sector: 1.39 Industry: 1.39

BVPS

10.61

Sector: 1.80 Industry: 1.80

EPS

0.51

Sector: -2.21 Industry: -2.21

EQUITY-TO-ASSETS RATIO

0.60

Sector: 0.41 Industry: 0.41

LIABILITIES / ASSETS

0.40

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

31.65%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

21.05%

Sector: - Industry: -

FAIR VALUE OF Luminex ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 13.16

Fair Value

$ 11.03

Upside Return potential.

-16.15%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LMNX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	27.58	7.15	25.92%	2.18%	$ 580.26 B	21.83%
PFE	19.91	1.65	8.29%	6.56%	$ 149.16 B	11.83%
ABBV	110.89	-60.96	-54.98%	2.96%	$ 403.08 B	5.79%
NVO	65.46	40.20	61.41%	4.25%	$ 195.21 B	37.07%
MRK	32.94	6.41	19.45%	2.79%	$ 294.29 B	13.59%
AZN	26.65	5.84	21.93%	1.79%	$ 276.88 B	17.19%
GILD	16.93	6.66	39.33%	2.54%	$ 155.98 B	30.99%
BMY	16.00	5.79	36.19%	4.38%	$ 116.43 B	15.01%
ZTS	12.70	10.39	81.75%	2.59%	$ 33.58 B	27.79%
REGN	14.39	2.03	14.08%	0.59%	$ 63.66 B	29.65%
HALO	23.51	37.34	158.82%	0.00%	$ 8.20 B	23.13%
AMGN	24.59	20.87	84.87%	2.76%	$ 191.81 B	20.96%
MCK	20.09	-114.69	-570.98%	0.40%	$ 95.65 B	1.18%
HRMY	13.72	2.20	16.00%	0.00%	$ 2.00 B	16.20%
VRTX	26.05	5.84	22.41%	0.00%	$ 113.01 B	35.51%
CAH	33.83	-19.69	-58.20%	0.91%	$ 52.60 B	0.62%
ADMA	11.72	4.96	42.37%	0.00%	$ 1.94 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LMNX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/15/2021	07/08/2021	0,10000000
Dividends	03/23/2021	04/15/2021	0,10000000
Dividends	12/21/2020	01/14/2021	0,10000000
Dividends	09/22/2020	10/15/2020	0,09000000
Dividends	06/16/2020	07/09/2020	0,09000000
Dividends	03/17/2020	04/09/2020	0,09000000
Dividends	12/17/2019	01/15/2020	0,09000000
Dividends	09/24/2019	10/17/2019	0,09000000
Dividends	06/18/2019	07/11/2019	0,06000000
Dividends	03/19/2019	04/11/2019	0,06000000
Dividends	12/18/2018	01/10/2019	0,06000000
Dividends	09/19/2018	10/12/2018	0,06000000
Dividends	06/20/2018	07/13/2018	0,06000000
Dividends	03/21/2018	04/13/2018	0,06000000
Dividends	12/20/2017	01/12/2018	0,06000000
Dividends	09/20/2017	10/13/2017	0,06000000
Dividends	06/21/2017	07/14/2017	0,06000000
Dividends	03/22/2017	04/14/2017	0,06000000

ABOUT Luminex

Luminex Corporation

Average Investor10 user rating

4.0 (0 people)

United States

31 years

Founded: 1995

2000

Time since IPO - 26 years

1.325

Employees

Luminex Corporation (United States) is listed on the Nasdaq and has a market capitalization of $605.30 Millions, with shareholders equity totaling $488.05 Millions.

The company employs approximately 1.325 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Luminex Corporation reported $437.66 Millions in revenue, generating net income of $23.60 Millions.

Key financial metrics include a P/E ratio of 25.65, a price-to-book (P/B) ratio of 1.24, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LMNX.

Market cap

$ 605.30 Millions

Net worth

$ 488.05 Millions

$ 488,050,000.00

Assets

$ 819.03 Millions

$ 819,030,000.00

Total Shares Outstanding

46.00 Millions

46,000,000

Average Daily Trading Volume

$ 36.11 Thousand

$ 36,110.00

Sector

Health Care

Industry

Biotechnology

LMNX

LMNX revenue and profits

Financial Results LMNX

DRAG THE FRAME TO SEE MORE DATA

LMNX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 784.05 8,10% (12M)

P/E

20.09

0.40%

ROE

-570.98%

P/BV

-114.69

CAH - Cardinal Health

$ 223.85 40,27% (12M)

P/E

33.83

0.91%

ROE

-58.20%

P/BV

-19.69

JNJ - Johnson & Johnson

$ 240.87 57,17% (12M)

P/E

27.58

2.18%

ROE

25.92%

P/BV

7.15

MRK - Merck & Co.

$ 119.05 50,96% (12M)

P/E

32.94

2.79%

ROE

19.45%

P/BV

6.41

AZN - AstraZeneca

$ 178.75 23,65% (12M)

P/E

26.65

1.79%

ROE

21.93%

P/BV

5.84

ABBV - AbbVie

$ 227.73 22,97% (12M)

P/E

110.89

2.96%

ROE

-54.98%

P/BV

-60.96

PFE - Pfizer

$ 26.21 14,30% (12M)

P/E

19.91

6.56%

ROE

8.29%

P/BV

1.65

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 784.05 8,10% (12 M)

P/L

20.09

0.40%

ROE

-570.98%

P/VP

-114.69

CAH - Cardinal Health

$ 223.85 40,27% (12 M)

P/L

33.83

0.91%

ROE

-58.20%

P/VP

-19.69

JNJ - Johnson & Johnson

$ 240.87 57,17% (12 M)

P/L

27.58

2.18%

ROE

25.92%

P/VP

7.15

MRK - Merck & Co.

$ 119.05 50,96% (12 M)

P/L

32.94

2.79%

ROE

19.45%

P/VP

6.41

AZN - AstraZeneca

$ 178.75 23,65% (12 M)

P/L

26.65

1.79%

ROE

21.93%

P/VP

5.84

ABBV - AbbVie

$ 227.73 22,97% (12 M)

P/L

110.89

2.96%

ROE

-54.98%

P/VP

-60.96

PFE - Pfizer

$ 26.21 14,30% (12 M)

P/L

19.91

6.56%

ROE

8.29%

P/VP

1.65

Frequently Asked Questions

What is the price of Luminex (LMNX) today?

The current price of Luminex (LMNX) is $ 13.16, representing a 0% gain over the past year. The stock began the year trading around $ 29.72 and is currently priced at $ 13.16. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Luminex (LMNX) pay dividends?

Luminex (LMNX) did not pay dividends over the past year.

Is Luminex (LMNX) a good investment?

Luminex (LMNX) is currently trading at $ 13.16 with a P/E ratio of 25.65. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Luminex (LMNX) stock?

You can buy Luminex (LMNX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol LMNX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Luminex (LMNX) yield today?

Over the past month, Luminex (LMNX) has returned 9.10% — 0.00% over the past year, and -64.32% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Luminex (LMNX) today at the current price of $ 13.16 your total investment would be $ 1,315.87.

Based on historical performance, the investment would have grown to approximately:

$ 1,315.87 after 1 year
$ 469.50 after 5 years
$ 897.03 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LMNX

Luminex Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LMNX

review the fundamentals of Luminex shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Luminex

Luminex Corporation

United States

31 years

2000

1.325

PROFIT X PRICE LMNX

Financial Results LMNX

LMNX cash flow

Asset, Revenue and Profit Growth - LMNX

LMNX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

Frequently Asked Questions